The new blockbuster blood thinner Pradaxa may present serious risks of heart attacks and spontaneous bleeding events, according to a study published by the Archives of Internal Medicine. Pradaxa was approved by the Food and Drug Administration (FDA) in October 2010 for the prevention of strokes in patients with a type of irregular heartbeat known as atrial fibrillation (AF). It was the first anticoagulant approved for such use since warfarin (Coumadin) more than 50 years ago. What had members of the health care community so in favor of the new drug was that patients on warfarin have to be monitored ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.